中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:( Shenglan ZHANG)

1.OBSERVATION OF ELEVEN IMMUNOLOGIC INDEXES IN IDDM

Shenglan ZHANG

Chinese Journal of Endocrinology and Metabolism 1986;0(04):-

2.Basal-like breast cancer

Shenglan LI ; Qingyuan ZHANG

Journal of International Oncology 2012;39(5):377-380

3.James Sheehy Myringoplasty

Shankai YIN ; Shenglan ZHANG ; Wenying LU

Journal of Audiology and Speech Pathology 1998;0(01):-

4.Intratympanic Gentamycin for Intractable Meniere Disease

Yaqin WU ; Shankai YIN ; Shenglan ZHANG

Journal of Audiology and Speech Pathology 1998;0(01):-

5.HLA-DPB1, DQB1 genes and their correlation with autoantibodies in type 1 diabetes mellitus

Wanjia XING ; Shenglan ZHANG ; Bingshen KE

Chinese Journal of Endocrinology and Metabolism 2000;0(06):-

6.The ultrastrucural and immunohistochemical study of BBB in streptozocin induced hyperglycemic rats

Hui GUO ; Shenglan ZHANG ; Zhaoshu JIANG

Medical Journal of Chinese People's Liberation Army 1981;0(06):-

7.Effects of intensive insulin therapy on the activity of nuclear factor kappa B in PBMC of the patients with critical illness complicated by hyperglycemia

Shenglan ZHANG ; Qianwang LI ; Xihong FAN

Medical Journal of Chinese People's Liberation Army 1983;0(02):-

8.An observation on circulating NO and endothelin levels in diabetic nephropathy

Shenglan ZHANG ; Wanjia XING ; Hui YAN ; Suxia WANG ; Jing LI ;

Chinese Journal of Diabetes 1995;0(04):-

9.Lipid-lowering effects of gallic acid on glutamate-induced obese mice

Xu ZHANG ; Chaoyin CHEN ; Junlin DONG ; Jinyan CAI ; Shenglan ZHAO

Chinese Traditional Patent Medicine 2017;39(6):1115-1119

10.Curative Efficacy of Decitabine Combine with CAG Gegimen in Treatment of Acute Myeloid Leukemia and Its Effects on IFN-γ, HBDH and LDH Levels

Na ZHANG ; Yongqian JIA ; Shenglan QING ; Feng XU ; Jie ZHOU

Progress in Modern Biomedicine 2017;17(25):4963-4966

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO